ArticleFood science and biotechnology2025
Terpenoids from quinoa suppresses breast cancer migration by down-regulating the miR-21-5p.
Article in Food science and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is the most common malignant tumor in women. It has metastasis as the primary cause of death and chemotherapy failure among patients. Terpenoids possess significant anti-tumor compounds found in natural products. In the present study, a terpenoid ingredient with anti-breast cancer from quinoa was extracted, and named QBT (Quinoa bran terpenoids). The analysis of western blot indicated that QBT inhibited breast cancer cell migration by reversing Epithelial Mesenchymal Transition (EMT). RT-PCR results showed that miR-21-5p expression was significantly down-regulated after QBT treatment. Further studies demonstrated that miR-21-5p was involved in inhibiting the metastasis of breast cancer by regulating PTEN/PI3K/AKT signaling pathway. In conclusion, the study reveals the inhibitory mechanism of QBT and provides insights into the key role of the miR-21-5p/PTEN/PI3K/Akt on breast cancer migration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.